A regulatory non-interventional study to monitor the safety and efficacy of JARDIANCE® (Empagliflozin 10 mg) in Korean patients with Chronic Kidney Disease (CKD)

24/10/2023
05/02/2025
EU PAS number:
EUPAS107293
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

[Eng]1245-0323-onis-protocol-final-v2-EUPAS.pdf

English (654.31 KB - PDF) View document
Updated protocol

1245-0323-protocol-v3-final_Redacted.pdf

First published: 04/02/2025
English (1021.66 KB - PDF) View document
Study results
Study report
Other information